Literature DB >> 30252581

Chylous Ascites in an Infant with Thanatophoric Dysplasia Type I with FGFR3 Mutation Surviving Five Months.

Jeon Soo-Kyeong1,2, Narae Lee1,2, Mi Hye Bae2,3, Young Mi Han1,2, Kyung Hee Park2,3, Shin Yun Byun1,2.   

Abstract

BACKGROUND: Thanatophoric dysplasia (TD) results from sporadic de novo mutations in the FGFR3 gene. Upon confirming intrauterine diagnosis of this perinatal disease, pregnancy termination is recommended. There is limited information on the natural history of longer-term survivors with type 1 TD. CASE REPORT: A full-term neonate was confirmed via postnatal genetic testing to have type 1 TD. At 28 days, chylous ascites developed. Medium-chain triglyceride use improved the ascites. Cerebral ventriculomegaly worsened throughout life. Death due to respiratory failure occurred at age 5 months.
CONCLUSION: The chylous ascites in this child with type 1 TD and survival past the neonatal stage suggests that type 1 TD may be accompanied by abnormalities of the lymphatic channels. Moreover, ventriculomegaly can be progressive.

Entities:  

Keywords:  Fibroblast growth factor receptor 3 () gene; chylous ascites; dwarfism; thanatophoric dysplasia

Mesh:

Substances:

Year:  2018        PMID: 30252581     DOI: 10.1080/15513815.2018.1504843

Source DB:  PubMed          Journal:  Fetal Pediatr Pathol        ISSN: 1551-3815            Impact factor:   0.958


  1 in total

1.  Should We Stop Calling Thanatophoric Dysplasia a Lethal Condition? A Case Report of a Long-Term Survivor.

Authors:  Ricki S Carroll; Angela L Duker; Andrea J Schelhaas; Mary Ellen Little; Elissa G Miller; Michael B Bober
Journal:  Palliat Med Rep       Date:  2020-05-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.